Mouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157: H7

FEMS Immunology and Medical Microbiology

Volumn 63, Issue 3, 2011, Pages 427-434

  Kim, Sang Hyun ^a   Lee, Yong Hoon ^a   Lee, Sang Ho ^a   Lee, Sang Rae ^a   Huh, Jae Won ^a   Kim, Sun Uk ^a   Chang, Kyu Tae ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Hemolytic uremic syndrome; Lipopolysaccharide; Outer membrane vesicles; Shiga toxin

Indexed keywords

LIPOPOLYSACCHARIDE; MITOMYCIN C; SHIGA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BLOOD CELL COUNT; BLOOD CHEMISTRY; ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; INOCULATION; MALE; MEMBRANE VESICLE; MOUSE; NONHUMAN; OUTER MEMBRANE VESICLE; PRIORITY JOURNAL; VITAL SIGN;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI O157; EXOSOMES; HEMOLYTIC-UREMIC SYNDROME; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; SHIGA TOXIN 2;

EID: 80755126965     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00869.x     Document Type: Article

References (25)

1. Acheson DW, Moore R, De Breucker S, Lincicome L, Jacewicz M, Skutelsky E & Keusch GT (1996) Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect Immun 64: 3294-3300.
2. Cascales E, Bernadac A, Gavioli M, Lazzaroni J-C & Lloubes R (2002) Pal lipoprotein of Escherichia coli plays a major role in outer membrane integrity. J Bacteriol 184: 754-759.
3. Chart H, Smith HR, Scotland SM, Rowe B, Milford DV & Taylor CM (1991) Serological identification of Escherichia coli O157:H7 infection in haemolytic uremic syndrome. Lancet 337: 138-140.
4. Fisseha M, Chen P, Brandt B, Kijek T, Moran E & Zollinger W (2005) Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect Immun 73: 4070-4080.
5. Hayashi T, Makino K, Ohnishi M et al. (2001) Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 8: 11-22.
6. Hurley BP, Thorpe CM & Acheson DWK (2001) Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect Immun 69: 6148-6155.
7. Ikeda M, Ito S & Honda M (2004) Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol 19: 485-489.
8. Keepers TR, Psotka MA, Gross LK & Obrig TG (2006) A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17: 3404-3414.
9. Kim S-H, Kim K-S, Lee S-R, Kim E, Kim M-S, Lee E-Y, Gho YS, Kim J-W, Bishop RE & Chang K-T (2009) Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. Biochim Biophys Acta 1788: 2150-2159.
10. Kim S-H, Lee S-R, Kim K-S, Ko A, Kim E, Kim Y-H & Chang K-T (2010) Shiga toxin A subunit mutant of Escherichia coli O157:H7 releases outer membrane vesicles containing the B-pentameric complex. FEMS Immunol Med Microbiol 58: 412-420.
11. Kolling GL & Matthews KR (1999) Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol 65: 1843-1848.
12. Kuehn MJ & Kesty NC (2005) Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 19: 2645-2655.
13. Lingwood CA (1996) Role of verotoxin receptors in pathogenesis. Trends Microbiol 4: 147-153.
14. Malyukova I, Murray KF, Zhu C, Boedeker E, Kane A, Patterson K, Peterson JR, Donowitz M & Kovbasnjuk O (2009) Macropinocytosis in Shiaga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis. Am J Physiol Gastrointest Liver Physiol 296: G78-G92.
15. Mühldorfer I, Hacker J, Keusch GT, Acheson DW, Tschäpe H, Kane AV, Ritter A, Ölschläger T & Donohue-Rolfe A (1996) Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun 64: 495-502.
16. Murphy KC, Ritchie JM, Waldor MK, Lobner-Olesen A & Marinus MG (2008) Dam methyltransferase is required for stable lysogeny of the Shiga toxin (Stx2)-encoding bacteriophage 933W of enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 190: 438-441.
17. Obrig TG (2010) Escherichia coli Shiga toxin mechanisms of action in renal disease. Toxins 2: 2769-2794.
18. Paixao-Cavalcante D, Botto M, Cook HT & Pickering MC (2008) Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice. Clin Exp Immunol 155: 339-347.
19. Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW & Obrig TG (2009) Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 77: 959-969.
20. Shimizu K, Asahara T, Nomoto K, Tanaka R, Hamabata T, Ozawa A & Takeda Y (2003) Deveolopment of a lethal Shiga toxin-producing Escherichia coli-infection mouse model using multiple mitomycin C treatment. Microb Pathog 35: 1-9.
21. Stahl A, Sartz L, Nelsson A, Bekassy ZD & Karpman D (2009) Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS ONE 4: e6990.
22. Tarr PI, Gordon CA & Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086.
23. Teghanemt A, Zhang D, Levis EN, Weiss JP & Gioannini TL (2005) Molecular basis of reduced potency of underacylated endotoxins. J Immunol 175: 4669-4676.
24. Wadolkowski EA, Sung LM & Burris JA (1990) Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 58: 3959-3965.
25. Yoon JW & Hovde CJ (2008) All blood, no stool: enterohemorrhagic Escherichia coli O157:H7 infection. J Vet Sci 9: 219-231.